.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Roland Goldbrunner

Further involvements

27/10/2022
14:00 – 14:15 10 Min. 5 Min.
Abstractvortrag
Expression of YAP and TAZ in brain tumors from different age groups
27/10/2022
14:15 – 14:30 10 Min. 5 Min.
Abstractvortrag
YAP and TAZ expression in benign pediatric brain tumors with high levels in choroid plexus papillomas
27/10/2022
16:35 – 16:45 7 Min. 3 Min.
Abstractvortrag
Voxel-based lesion symptom mapping of deficits of the lexical word fluency in patients with glioblastoma
28/10/2022
10:15 – 10:25 7 Min. 3 Min.
Abstractvortrag
Processing times of visuospatial standard neurocognition tests depicting deficits linked to the right perisylvian network
28/10/2022
10:25 – 10:35 7 Min. 3 Min.
Abstractvortrag
Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients
28/10/2022
11:40 – 11:55 10 Min. 5 Min.
Abstractvortrag
Paired-pulse TMS for mapping cortical language areas – A proof-of-principle study
28/10/2022
11:55 – 12:05 7 Min. 3 Min.
Abstractvortrag
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy – the MecMeth/NOA-24 trial study protocol
28/10/2022
15:45 – 15:55 7 Min. 3 Min.
Abstractvortrag
Multi-task fMRI-informed tractography to optimize the resection of brain tumours in funcionally eloquent locations
28/10/2022
16:00 – 16:15 10 Min. 5 Min.
Abstractvortrag
Tractography of the language network's dorsal and ventral streams informed by clustered sparse sampling fMRI of two distinct language tasks
29/10/2022
09:10 – 09:20 7 Min. 3 Min.
Abstractvortrag
Prognostic impact of obesity in newly-diagnosed glioblastoma: A secondary analysis of CeTeG/NOA-09 and GLARIUS
29/10/2022
09:30 – 09:40 7 Min. 3 Min.
Abstractvortrag
Daily activity, sleep, and neurocognitive functioning under TTFields therapy for glioblastoma in Germany in Routine Clinical Care (TIGER PRO-Active Study)